|
A new study indicates that omega-3 fatty acid docosahexaenoic acid (DHA) may bring relief to people suffering from atopic eczema.
DHA was shown to improve eczema by about 23 per cent over an eight weeks period, and this was associated with significant reductions in levels of markers of inflammation, according to results published in the British Journal of Dermatology. The researcher recruited 53 people with atopic eczema (average age 26.6) and randomly assigned them to receive either a daily supplement of DHA (5.4 grams) or a control of saturated fatty acids with an equal caloric value. fter eight weeks, Worm and co-workers report that the severity scoring of atopic dermatitis (SCORAD) reduced from 37.0 to 28.5 in the DHA group, and by 35.4 to 33.4 in the control group. DHA, but not the control treatment, resulted in a significant clinical improvement of atopic eczema in terms of a decreased SCORAD. In terms of markers of inflammation and immune response, as measured by production of immunoglobulin E (IgE), were affected only in the DHA group.
Reference: C. Koch C. et al Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. British Journal of Dermatology. 158 (4) 786-792
Sphere Healthcare is a leading manufacturer of softgels including fish oils. Many specific fish oils and ultra purified oils are available from Sphere in a variety of capsule shapes and sizes. For further information, please contact Sphere Healthcare customer service.
|
